A benignus prostata-hyperplasia gyógyszeres kezelése

Translated title of the contribution: Conservative treatment of benign prostatic hyperplasia

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Medical treatment of benign prostatic hyperplasia is reviewed by the author. Experiences with herbal extracts have been known for more than 2 decades. Treating benign prostatic hyperplasia with these extracts is recommended in initial phase. Prostate volume is decreased and mechanical component of dysuria is improved by treating for a long time (months, years) with 5-alfa-reductase finasterid which contains hormone. This drug is indicated when volume of the prostate is over 40 g. Dynamical component of benign prostatic hyperplasia is treated with α-receptor blockers which act on the bladder neck. These medicines have effects earlier and are recommended for all patients with benign prostatic hyperplasia independently of prostate volume. These might have some side effects like hypotension. The improving effects of 5 phosphodiestherase inhibitors on BPH have been discovered recently. The same effect has been described of alpha-blockers on sexual activity.

Original languageHungarian
Pages (from-to)1875-1880
Number of pages6
JournalOrvosi Hetilap
Volume149
Issue number40
DOIs
Publication statusPublished - Oct 5 2008

Fingerprint

Prostatic Hyperplasia
Prostate
Cholestenone 5 alpha-Reductase
Dysuria
Sexual Behavior
Hypotension
Urinary Bladder
Hormones
Conservative Treatment
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A benignus prostata-hyperplasia gyógyszeres kezelése. / Romics, I.

In: Orvosi Hetilap, Vol. 149, No. 40, 05.10.2008, p. 1875-1880.

Research output: Contribution to journalArticle

@article{c7e6dcb175e84f3c8c93495a49a5017f,
title = "A benignus prostata-hyperplasia gy{\'o}gyszeres kezel{\'e}se",
abstract = "Medical treatment of benign prostatic hyperplasia is reviewed by the author. Experiences with herbal extracts have been known for more than 2 decades. Treating benign prostatic hyperplasia with these extracts is recommended in initial phase. Prostate volume is decreased and mechanical component of dysuria is improved by treating for a long time (months, years) with 5-alfa-reductase finasterid which contains hormone. This drug is indicated when volume of the prostate is over 40 g. Dynamical component of benign prostatic hyperplasia is treated with α-receptor blockers which act on the bladder neck. These medicines have effects earlier and are recommended for all patients with benign prostatic hyperplasia independently of prostate volume. These might have some side effects like hypotension. The improving effects of 5 phosphodiestherase inhibitors on BPH have been discovered recently. The same effect has been described of alpha-blockers on sexual activity.",
keywords = "Benign prostatic hyperplasia, Medical treatment",
author = "I. Romics",
year = "2008",
month = "10",
day = "5",
doi = "10.1556/OH.2008.28462",
language = "Hungarian",
volume = "149",
pages = "1875--1880",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "40",

}

TY - JOUR

T1 - A benignus prostata-hyperplasia gyógyszeres kezelése

AU - Romics, I.

PY - 2008/10/5

Y1 - 2008/10/5

N2 - Medical treatment of benign prostatic hyperplasia is reviewed by the author. Experiences with herbal extracts have been known for more than 2 decades. Treating benign prostatic hyperplasia with these extracts is recommended in initial phase. Prostate volume is decreased and mechanical component of dysuria is improved by treating for a long time (months, years) with 5-alfa-reductase finasterid which contains hormone. This drug is indicated when volume of the prostate is over 40 g. Dynamical component of benign prostatic hyperplasia is treated with α-receptor blockers which act on the bladder neck. These medicines have effects earlier and are recommended for all patients with benign prostatic hyperplasia independently of prostate volume. These might have some side effects like hypotension. The improving effects of 5 phosphodiestherase inhibitors on BPH have been discovered recently. The same effect has been described of alpha-blockers on sexual activity.

AB - Medical treatment of benign prostatic hyperplasia is reviewed by the author. Experiences with herbal extracts have been known for more than 2 decades. Treating benign prostatic hyperplasia with these extracts is recommended in initial phase. Prostate volume is decreased and mechanical component of dysuria is improved by treating for a long time (months, years) with 5-alfa-reductase finasterid which contains hormone. This drug is indicated when volume of the prostate is over 40 g. Dynamical component of benign prostatic hyperplasia is treated with α-receptor blockers which act on the bladder neck. These medicines have effects earlier and are recommended for all patients with benign prostatic hyperplasia independently of prostate volume. These might have some side effects like hypotension. The improving effects of 5 phosphodiestherase inhibitors on BPH have been discovered recently. The same effect has been described of alpha-blockers on sexual activity.

KW - Benign prostatic hyperplasia

KW - Medical treatment

UR - http://www.scopus.com/inward/record.url?scp=55049131415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55049131415&partnerID=8YFLogxK

U2 - 10.1556/OH.2008.28462

DO - 10.1556/OH.2008.28462

M3 - Article

VL - 149

SP - 1875

EP - 1880

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 40

ER -